Pancreatic Islet Cell Transplantation
Customize your policy alerts
Sign up for healthplanofupperohiovalley Policy 19215698 alerts
Get alerted when Policy 19215698 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical necessity and coding for allogeneic pancreatic islet cellular therapy and autologous pancreatic islet transplantation, including excluded or investigational islet-related services.
A new policy establishes coverage criteria for allogeneic pancreatic islet cellular therapy and autologous islet transplantation.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.